Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 31, 1996 - Issue 12
Submit an article Journal homepage
10
Views
50
CrossRef citations to date
0
Altmetric
Original Article

Intragastric pH during Treatment with Omeprazole: Role of Helicobacter pylori and H. pylori-Associated Gastritis

E. F. Verdú Division of Gastroenterology, CHUV, Lausanne, Switzerland; Division of Gastroenterology, McMaster University, Hamilton, Ontario, Canada; Astra Hässle AB, Mölndal, Sweden; Division of Gastroenterology, Elisabeth Krankenhaus, Essen, Germany; Institute of Pathology, Klinikum Bayreuth, Bayreuth, Germany
,
D. Armstrong Division of Gastroenterology, CHUV, Lausanne, Switzerland; Division of Gastroenterology, McMaster University, Hamilton, Ontario, Canada; Astra Hässle AB, Mölndal, Sweden; Division of Gastroenterology, Elisabeth Krankenhaus, Essen, Germany; Institute of Pathology, Klinikum Bayreuth, Bayreuth, Germany
,
J.-P. Idström Division of Gastroenterology, CHUV, Lausanne, Switzerland; Division of Gastroenterology, McMaster University, Hamilton, Ontario, Canada; Astra Hässle AB, Mölndal, Sweden; Division of Gastroenterology, Elisabeth Krankenhaus, Essen, Germany; Institute of Pathology, Klinikum Bayreuth, Bayreuth, Germany
,
J. Labenz Division of Gastroenterology, CHUV, Lausanne, Switzerland; Division of Gastroenterology, McMaster University, Hamilton, Ontario, Canada; Astra Hässle AB, Mölndal, Sweden; Division of Gastroenterology, Elisabeth Krankenhaus, Essen, Germany; Institute of Pathology, Klinikum Bayreuth, Bayreuth, Germany
,
M. Stolte Division of Gastroenterology, CHUV, Lausanne, Switzerland; Division of Gastroenterology, McMaster University, Hamilton, Ontario, Canada; Astra Hässle AB, Mölndal, Sweden; Division of Gastroenterology, Elisabeth Krankenhaus, Essen, Germany; Institute of Pathology, Klinikum Bayreuth, Bayreuth, Germany
,
G. Börsch Division of Gastroenterology, CHUV, Lausanne, Switzerland; Division of Gastroenterology, McMaster University, Hamilton, Ontario, Canada; Astra Hässle AB, Mölndal, Sweden; Division of Gastroenterology, Elisabeth Krankenhaus, Essen, Germany; Institute of Pathology, Klinikum Bayreuth, Bayreuth, Germany
&
A. L. Blum Division of Gastroenterology, CHUV, Lausanne, Switzerland; Division of Gastroenterology, McMaster University, Hamilton, Ontario, Canada; Astra Hässle AB, Mölndal, Sweden; Division of Gastroenterology, Elisabeth Krankenhaus, Essen, Germany; Institute of Pathology, Klinikum Bayreuth, Bayreuth, Germany
 show all
Pages 1151-1156 | Received 22 Mar 1996, Accepted 09 Jul 1996, Published online: 08 Jul 2009

Citations (50)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Cristina Borao Laguna & Angel Lanas. (2023) Advances in the pharmacotherapeutic management of refractory peptic ulcers. Expert Opinion on Pharmacotherapy 24:7, pages 825-833.
Read now
R. J. L. F. Loffeld & R. W. M van der Hulst. (2002) Helicobacter pylori and Gastro-oesophageal Reflux Disease: Association and Clinical Implications: To Treat or Not to Treat with anti- H. pylori Therapy?. Scandinavian Journal of Gastroenterology 37:236, pages 15-18.
Read now
M. Sagar, R. Seensalu, G. Tybring, M.-L. Dahl, L. Bertilsson. (1998) CYP2C19 Genotype and Phenotype Determined with Omeprazole in Patients with Acid-Related Disorders with and without Helicobacter pylori Infection. Scandinavian Journal of Gastroenterology 33:10, pages 1034-1038.
Read now

Articles from other publishers (47)

Prateek Padole, Piyush Ranjan, Munish Sachdeva & Mandhir Kumar. (2021) Role of Helicobacter pylori eradication in patients with functional dyspepsia. Indian Journal of Gastroenterology 40:5, pages 492-501.
Crossref
Majid T. Moghadam, Zahra Chegini, Amin Norouzi, Amin S. Dousari & Aref Shariati. (2021) Three-Decade Failure to the Eradication of Refractory Helicobacter pylori Infection and Recent Efforts to Eradicate the Infection. Current Pharmaceutical Biotechnology 22:7, pages 945-959.
Crossref
Carlos Martín de Argila de Prados. (2010) Evidencias e incertidumbres del uso clínico de los inhibidores de la bomba de protones. Gastroenterología y Hepatología 33, pages 5-10.
Crossref
Asghar Qasim, Colm A. O’Morain & Humphrey J. O’Connor. (2009) Helicobacter pylori eradication: role of individual therapy constituents and therapy duration . Fundamental & Clinical Pharmacology 23:1, pages 43-52.
Crossref
L. LUNDELL, N. HAVU, P. MIETTINEN, H. E. MYRVOLD, L. WALLIN, R. JULKUNEN, K. LEVANDER, J. G. HATLEBAKK, B. LIEDMAN, M. LAMM, A. MALM & A. WALAN. (2006) Changes of gastric mucosal architecture during long-term omeprazole therapy: results of a randomized clinical trial. Alimentary Pharmacology and Therapeutics 23:5, pages 639-647.
Crossref
Herbert Koop. (2006) Gastroösophageale Refluxkrankheit: wirklich ein interdisziplinäres Krankheitsbild in der Viszeralmedizin?. Visceral Medicine 22:1, pages 43-47.
Crossref
HUCK JOO TAN, ABDUL MANAF RIZAL, MOHAMED-YUSOFF ROSMADI & KHEAN-LEE GOH. (2006) Role of Helicobacter pylori virulence factor and genotypes in non-ulcer dyspepsia . Journal of Gastroenterology and Hepatology 21:1, pages 110-115.
Crossref
B. DELANEY & K. McCOLL. (2005) Review article: Helicobacter pylori and gastro-oesophageal reflux disease. Alimentary Pharmacology and Therapeutics 22:s1, pages 32-40.
Crossref
C. Scarpignato. (2005) Antisecretory drugs, Helicobacter pylori infection and symptom relief in GORD: Still an unexplored triangle. Digestive and Liver Disease 37:7, pages 468-474.
Crossref
X. Calvet & A. Lanas. (2005) Helicobacter pylori y gastroprotección. Reumatología Clínica 1:1, pages 3-6.
Crossref
Javier P. Gisbert & Josep M. Piqué. (2005) Indicaciones y consecuencias de la erradicación de Helicobacter pylori en la enfermedad por reflujo gastroesofágico. Medicina Clínica 124:18, pages 697-709.
Crossref
Ahmed Madisch. (2005) Management of functional dyspepsia: Unsolved problems and new perspectives. World Journal of Gastroenterology 11:42, pages 6577.
Crossref
Xavier Calvet & Fernando Gomoll??n. (2005) What is Potent Acid Inhibition, and How Can it be Achieved?. Drugs 65:Supplement 1, pages 13???23.
Crossref
Jan Mart??nek, Drahoslava Pantofl????kov??Tom???? Hucl, Marek Bene??Gian Dorta, Milan Luk????Julius ??pi????k. (2004) Absence of nocturnal acid breakthrough in Helicobacter pylori-positive subjects treated with twice-daily omeprazole. European Journal of Gastroenterology & Hepatology 16:5, pages 445-450.
Crossref
Francesco Di Mario, Anna Ingegnoli, Nadia Dal Bo, Giulia Martina Cavestro, Ali M. Moussa, Lucas Giovanni Cavallaro, Giovanni Aragona, Veronica Iori, Alberto Pilotto, Angelo Franze & Massimo Rugge. (2004) Early Epigastric Pain After PPI Administration: Exacerbation of Helicobacter pylori Corpus Gastritis?. Helicobacter 9:1, pages 92-94.
Crossref
MASAHIKO INAMORI, JUN-ICHI TOGAWA, HIROKAZU TAKAHASHI, MASATO YONEDA, NOBUTAKA FUJISAWA, TOMOYUKI IWASAKI, YUTAKA OZAWA, TAISUKE KIKUCHI, KENICHI MURAMATSU, GAKU CHIGUCHI, SHUHEI MATSUMOTO, HARUNOBU KAWAMURA, YASUNOBU ABE, HIROYUKI KIRIKOSHI, NORITOSHI KOBAYASHI, TAKASHI SAKAGUCHI, TOMOO TAKAMURA, ATSUSHI NAKAJIMA, NORIO UENO & HISAHIKO SEKIHARA. (2003) Comparison of the effect on intragastric pH of a single dose of omeprazole or rabeprazole: Which is suitable for on-demand therapy?. Journal of Gastroenterology and Hepatology 18:9, pages 1034-1038.
Crossref
David Y Graham. (2003) The Changing Epidemiology of Gerd: Geography and Helicobacter Pylori. American Journal of Gastroenterology 98:7, pages 1462-1470.
Crossref
FRANCESCO DI MARIO, NADIA DAL BO, GIOVANNI ARAGONA, ALI M MOUSSA, VERONICA IORI, GIULIA M CAVESTRO, ALBERTO PILOTTO, GIOACCHINO LEANDRO, MARILISA FRANCESCHI, MASSIMO RUGGE & Angelo FRANZE. (2003) Rabeprazole in a one-week eradication therapy of Helicobacter pylori: Comparison of different dosages. Journal of Gastroenterology and Hepatology 18:7, pages 783-786.
Crossref
R JLF Loffeld. (2003) Re: Laine and Sugg— Helicobacter Pylori Eradication on Esophagitis and Gerd. American Journal of Gastroenterology 98:5, pages 1201-1202.
Crossref
M. P. Williams, B. Usselmann, A. Chilton, J. Sercombe, C. U. Nwokolo & R. E. Pounder. (2003) Eradication of Helicobacter pylori increases nocturnal intragastric acidity during dosing with rabeprazole, omeprazole, lansoprazole and placebo . Alimentary Pharmacology & Therapeutics 17:6, pages 775-783.
Crossref
J. Labenz. 2003. Helicobactor pylori. Helicobactor pylori 243 252 .
U. G. Meneghelli, S. Boaventura, J. P. P. Moraes-Filho, O. Leitão, A. P. FerrariJrJr, J. R. Almeida, A. F. N. Magalhães, L. P. Castro, M. T. Haddad, M. Tolentino, J. L. Jorge, E. Silva, I. Maguilnik & R. Fischer. (2002) Efficacy and tolerability of pantoprazole versus ranitidine in the treatment of reflux esophagitis and the influence of Helicobacter pylori infection on healing rate. Diseases of the Esophagus 15:1, pages 50-56.
Crossref
A. Qasim & C. A. O'Morain. (2002) Treatment of Helicobacter pylori infection and factors influencing eradication . Alimentary Pharmacology & Therapeutics 16, pages 24-30.
Crossref
David Armstrong, Pierre Pare, Dan Pericak & Myron Pyzyk. (2001) Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease1. The American Journal of Gastroenterology 96:10, pages 2849-2857.
Crossref
R.H. Hunt, K. Sumanac & J.-Q. Huang. (2001) Review article: should we kill or should we save Helicobacter pylori ? . Alimentary Pharmacology & Therapeutics 15, pages 51-59.
Crossref
Javier P. Gisbert y & José María Pajares. (2001) ¿Está indicado erradicar la infección por Helicobacter pylori en los pacientes que requieren tratamiento a largo plazo con inhibidores de la bomba de protones?. Medicina Clínica 117:20, pages 793-797.
Crossref
Ragnar BefritsSvante SjöstedtBengt Ödman, Heléne Sörngård & Greger Lindberg. (2008) Curing Helicobacter pylori Infection in Patients with Duodenal Ulcer Does Not Provoke Gastroesophageal Reflux Disease . Helicobacter 5:4, pages 202-205.
Crossref
P. Malfertheiner & C. Gerards. (2000) Helicobacter pylori infection and gastro-oesophageal reflux disease: coincidence or association?. Best Practice & Research Clinical Gastroenterology 14:5, pages 731-741.
Crossref
S. Vigneri, R. Termini, V. Savarino & F. Pace. (2000) Is Helicobacter pylori status relevant in the management of GORD?. Alimentary Pharmacology & Therapeutics 14, pages 31-42.
Crossref
Mohamed Sagar, Gunnel Tybring, Marja–Liisa Dahl, Leif Bertilsson & Rein Seensalu. (2000) Effects of omeprazole on intragastric pH and plasma gastrin are dependent on the CYP2C19 polymorphism. Gastroenterology 119:3, pages 670-676.
Crossref
K. Schutze. (2000) Helicobacter pylori und gastroosophageale Refluxkrankheit. Acta Medica Austriaca 27:4, pages 122-125.
Crossref
K. Schutze. (2000) Helicobacter pylori und gastroosophageale Refluxkrankheit. Acta Medica Austriaca 27:4, pages 122-125.
Crossref
K. Schütze. (2001) Helicobacter pylori und gastroösophageale Refluxkrankheit. Acta Medica Austriaca 27:4, pages 122-125.
Crossref
Akiko Shiotani, Zhannat Z. Nurgalieva, Yoshio Yamaoka & David Y. Graham. (2000) HELICOBACTER PYLORI. Medical Clinics of North America 84:5, pages 1125-1136.
Crossref
J. Martínek, L. Kužela, J. Špičák & A. Vavrečka. (2001) Review article: the clinical influence of Helicobacter pylori in effective acid suppression—implications for the treatment of gastro‐oesophageal reflux disease . Alimentary Pharmacology & Therapeutics 14:8, pages 979-990.
Crossref
Regina Lamberts. (2000) Morphological changes of the human gastric mucosa under long-term proton pump inhibitor therapy and their clinical relevance. Microscopy Research and Technique 48:6, pages 357-366.
Crossref
Ulrich Klotz. (2000) Pharmacokinetic Considerations in the Eradication of Helicobacter Pylori. Clinical Pharmacokinetics 38:3, pages 243-270.
Crossref
D. Y. Graham. 2000. Helicobacter pylori. Helicobacter pylori 453 459 .
Peters, Kuipers, Ganesh, Sluiter, Klinkenberg‐Knol, Lamers & Kleibeuker. (2001) The influence of Helicobacter pylori on oesophageal acid exposure in GERD during acid suppressive therapy . Alimentary Pharmacology & Therapeutics 13:7, pages 921-926.
Crossref
M. A. van Herwaarden, M. Samsom, C. H. M. van Nispen, P. G. H. Mulder & A. J. P. M. Smout. (1999) The effect of Helicobacter pylori eradication on intragastric pH during dosing with lansoprazole or ranitidine . Alimentary Pharmacology & Therapeutics 13:6, pages 731-740.
Crossref
B. E. Schenk, E. J. Kuipers, E. C. Klinkenberg-Knol, S. A. Eskes & S. G. M. Meuwissen. (1999) Helicobacter pylori and the Efficacy of Omeprazole Therapy for Gastroesophageal Reflux Disease. American Journal of Gastroenterology 94:4, pages 884-887.
Crossref
Y. Vandenplas. (1999) Helicobacter pylori infection. Clinical Microbiology and Infection 5:1, pages 1-11.
Crossref
Jia-Qing Huang & Richard H. Hunt. 1999. Proton Pump Inhibitors. Proton Pump Inhibitors 63 78 .
André L. Blum, Nicholas J. Talley, Colm O'Moráin, Sander Veldhuyzen van Zanten, Joachim Labenz, Manfred Stolte, Japie A. Louw, Arild Stubberöd, Asgeir Theodórs, Marie Sundin, Elisabeth Bolling-Sternevald & Ola Junghard. (1998) Lack of Effect of Treating Helicobacter pylori Infection in Patients with Nonulcer Dyspepsia . New England Journal of Medicine 339:26, pages 1875-1881.
Crossref
Williams, Sercombe, Hamilton & Pounder. (1998) A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects. Alimentary Pharmacology & Therapeutics 12:11, pages 1079-1089.
Crossref
Drahoslava Pantoflickova, AndréL. Blum & Hans R. Koelz. (1998) 7 Helicobacter pylori and functional dyspepsia: a real causal link?. Baillière's Clinical Gastroenterology 12:3, pages 503-532.
Crossref
Armstrong, VerdÚ, Berčík & Elchier. (2001) Letters to the Editors. Alimentary Pharmacology & Therapeutics 12:4, pages 395-396.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.